For one, this study does not address how higher expression of CD52 is induced in SLE patients or the milieu of soluble factors in patient serum as well as the potential effects of immunosuppressive therapies, both of which might influence CD52 expression. Here, CD52 is linked to systemic lupus erythematosus.